Labocanna S.A. (WSE:LCN)

Intra-Cellular Therapies Revenue

Labocanna had revenue of 153.12K PLN in the quarter ending March 31, 2025, with 88.20% growth. This brings the company's revenue in the last twelve months to 74.26K, down -14.76% year-over-year. In the year 2024, Labocanna had annual revenue of 1.01M with 6,023.39% growth.

• Revenue (ttm): 74.26K
• Revenue Growth: -14.76%
• P/S Ratio: 87.06
• Revenue / Employee: 24.75K
• Employees: 3
• Market Cap: 6.47M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.01M	994.94K	6,023.39%
Dec 31, 2023	16.52K	13.59K	463.37%
Dec 31, 2022	2.93K	952.00	48.08%
Dec 31, 2021	1.98K	-38.02K	-95.05%
Dec 31, 2020	40.00K	-49.40K	-55.26%